University · founded 1967
Louisiana State University in Shreveport
Shreveport, United States · lsus.edu
- Citations, last 5 years
- 9 108
- Works, last 5 years
- 1 510
- h-index
- 221
- Scientists listed
- 48
- Grants since 2016
- 319
Grants received
2019–2024 · research · R25
CURIOUS: Cardiovascular Undergraduate Research Initiative fOr Underrerepresented Students
Karen Y Stokes · Louisiana State University in Shreveport · funded by National Institutes of Health
2019–2023 · research · R01
Notch-enriched Mesenchymal Stromal Cells for Bone Allograft Repair
Yufeng Dong · Louisiana State University in Shreveport · funded by National Institutes of Health
2019–2024 · research · R01
Regulation of Legionella pneumophila pathogenesis by the central eukaryotic metabolic checkpoint kinase Mechanistic Target of Rapamycin (MTOR)
Stanimir Stefanov Ivanov · Louisiana State University in Shreveport · funded by National Institutes of Health
2019–2024 · research · R01
Notch-enriched Mesenchymal Stromal Cells for Bone Allograft Repair
Richard Shane Barton · Louisiana State University in Shreveport · funded by National Institutes of Health
2019–2025 · research · R01
Regulation of Legionella pneumophila pathogenesis by the central eukaryotic metabolic checkpoint kinase Mechanistic Target of Rapamycin (MTOR)
Stanimir Stefanov Ivanov · Louisiana State University in Shreveport · funded by National Institutes of Health
2019–2021 · research · R56
Late trafficking of incoming HPV16
Martin Sapp · Louisiana State University in Shreveport · funded by National Institutes of Health
2019–2024 · research · R01
Notch-enriched Mesenchymal Stromal Cells for Bone Allograft Repair
Richard Shane Barton · Louisiana State University in Shreveport · funded by National Institutes of Health
2019–2020 · research · R01
Prostate Cancer Health Disparity: Role of PDEF
Hari K Koul · Louisiana State University in Shreveport · funded by National Institutes of Health
2019–2024 · research · R01
Regulation of Legionella pneumophila pathogenesis by the central eukaryotic metabolic checkpoint kinase Mechanistic Target of Rapamycin (MTOR)
Stanimir Stefanov Ivanov · Louisiana State University in Shreveport · funded by National Institutes of Health
2019–2028 · research · R01
Novel Mechanisms of Cardiac Function and Dysfunction
Hind Lal · Louisiana State University in Shreveport · funded by National Institutes of Health
2018–2023 · program · P20
Center for Redox Biology and Cardiovascular Disease
Christopher G Kevil · Louisiana State University in Shreveport · funded by National Institutes of Health
2018–2022 · research · R01
EphA2 signaling in atherosclerotic fibroproliferative remodeling
Anthony Wayne Orr · Louisiana State University in Shreveport · funded by National Institutes of Health
2018–2022 · research · R01
EphA2 signaling in atherosclerotic fibroproliferative remodeling
Anthony Wayne Orr · Louisiana State University in Shreveport · funded by National Institutes of Health
2018–2023 · program · P20
SARS-CoV-2 Genomic Surveillance in North Louisiana
Christopher G Kevil · Louisiana State University in Shreveport · funded by National Institutes of Health
2018–2023 · program · P20
Center for Redox Biology and Cardiovascular Disease
Christopher G Kevil · Louisiana State University in Shreveport · funded by National Institutes of Health
2018–2023 · research · R01
Sigmar1 in lipid metabolism
Md. Shenuarin Bhuiyan · Louisiana State University in Shreveport · funded by National Institutes of Health
2018–2022 · research · R15
The role of alpha-synuclein in Snx3-retromer mediated recycling of membrane proteins
Stephan N. Witt · Louisiana State University in Shreveport · funded by National Institutes of Health
2018–2023 · program · P20
Center for Redox Biology and Cardiovascular Disease
Christopher G Kevil · Louisiana State University in Shreveport · funded by National Institutes of Health
2018–2023 · program · P20
Sex Differences in the Role of Hydrogen Sulfide in Alzheimer's Disease
Christopher G Kevil · Louisiana State University in Shreveport · funded by National Institutes of Health
2018–2023 · research · R01
Androgen Deprivation Activates Wnt/Beta-Catenin Signaling in Prostate Cancer
Xiuping Yu · Louisiana State University in Shreveport · funded by National Institutes of Health
2018–2022 · research · R15
Prenatal ethanol mediated regulation of bioactive lipid: Role of Autotaxin and LPP3 in Alzheimer disease.
Sumitra Miriyala · Louisiana State University in Shreveport · funded by National Institutes of Health
2018–2023 · program · P20
Center for Redox Biology and Cardiovascular Disease
Christopher G Kevil · Louisiana State University in Shreveport · funded by National Institutes of Health
2018–2022 · research · R01
Targeting Fibroblast Growth Factor Receptor-2b in prevention and treatment of cutaneous Squamous cell carcinoma.
John Digiovanni · Louisiana State University in Shreveport · funded by National Institutes of Health
2018–2022 · research · R15
Role of Actin in the Chromosomal Conformation & Nuclear Organization of HSP Genes
David Samuel Gross · Louisiana State University in Shreveport · funded by National Institutes of Health
2018–2028 · program · P20
Center for Redox Biology and Cardiovascular Disease
Christopher G Kevil · Louisiana State University in Shreveport · funded by National Institutes of Health
2018–2023 · research · R01
EphA2 signaling in atherosclerotic fibroproliferative remodeling
Anthony Wayne Orr · Louisiana State University in Shreveport · funded by National Institutes of Health
2018–2022 · research · R01
Targeting Fibroblast Growth Factor Receptor-2b in prevention and treatment of cutaneous Squamous cell carcinoma.
John Digiovanni · Louisiana State University in Shreveport · funded by National Institutes of Health
2018–2023 · research · R01
Androgen Deprivation Activates Wnt/Beta-Catenin Signaling in Prostate Cancer
Xiuping Yu · Louisiana State University in Shreveport · funded by National Institutes of Health
2018–2025 · research · R01
Sigmar1 in lipid metabolism
Md. Shenuarin Bhuiyan · Louisiana State University in Shreveport · funded by National Institutes of Health
2018–2024 · research · R01
Androgen Deprivation Activates Wnt/Beta-Catenin Signaling in Prostate Cancer
Xiuping Yu · Louisiana State University in Shreveport · funded by National Institutes of Health
2018–2023 · research · R01
Androgen Deprivation Activates Wnt/Beta-Catenin Signaling in Prostate Cancer
Xiuping Yu · Louisiana State University in Shreveport · funded by National Institutes of Health
2018–2022 · research · R01
EphA2 signaling in atherosclerotic fibroproliferative remodeling
Anthony Wayne Orr · Louisiana State University in Shreveport · funded by National Institutes of Health
2018–2022 · research · R15
Prenatal ethanol exposure alters lipid metabolism and cerebral microcirculation
Sumitra Miriyala · Louisiana State University in Shreveport · funded by National Institutes of Health
2018–2022 · research · R15
Neurotoxicity and nephrotoxicity of diglycolic acid: a model of calcium chelation-induced mitochondrial dysfunction
Kenneth E. Mcmartin · Louisiana State University in Shreveport · funded by National Institutes of Health
2018–2023 · program · P20
SARS-CoV-2 Genomic Surveillance in North Louisiana
Christopher G Kevil · Louisiana State University in Shreveport · funded by National Institutes of Health
2018–2023 · research · R01
Molecular signaling linking Alzheimer's disease and heart failure
Md. Shenuarin Bhuiyan · Louisiana State University in Shreveport · funded by National Institutes of Health
2018–2022 · research · R15
Chromosomal Conformation and Nuclear Organization of Heat Shock Protein Genes
David Samuel Gross · Louisiana State University in Shreveport · funded by National Institutes of Health
2018–2024 · research · R01
Targeting Fibroblast Growth Factor Receptor-2b in prevention and treatment of cutaneous Squamous cell carcinoma.
John Digiovanni · Louisiana State University in Shreveport · funded by National Institutes of Health
2018–2028 · program · P20
Center for Redox Biology and Cardiovascular Disease
Christopher G Kevil · Louisiana State University in Shreveport · funded by National Institutes of Health
2018–2022 · research · R01
Targeting Fibroblast Growth Factor Receptor-2b in prevention and treatment of cutaneous Squamous cell carcinoma.
John Digiovanni · Louisiana State University in Shreveport · funded by National Institutes of Health
